Giancarlo Zuliani and his team are dedicated to helping patients look and feel their best
Not approved for diagnostic, therapeutic, or medical applications
There is no redundancy
Hey skincare lovers, heres a secret tip for you
A dose of 40 mg once daily may be used for more severe symptoms or confirmed oesophagitis, as per clinical judgement Review at 612 weeks: Your team will assess symptom control and decide whether to continue, reduce, or stop the medication Beyond 12 weeks: Continued use only if clinically indicated for example, persistent GORD, endoscopic evidence of oesophagitis, or ongoing symptoms In line with NICE Key Therapeutic Topic KTT13 on proton pump inhibitors, the guiding principle is to use the lowest effective dose for the shortest clinically appropriate duration , with regular review and a step-down or tapering plan where possible
Important Information Store at controlled room temperature